Starr Christopher Minsider trades
In SEC Form 4 filings, Starr Christopher M is listed as Director of Monopar Therapeutics (MNPR). In the last 90 days, Starr Christopher M sold $659.4K of Monopar Therapeutics (MNPR) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| MNPRMonopar Therapeutics | Director | 5 | Oct 5 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-05
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| MNPRMonopar Therapeutics | Oct 1 | Oct 5 | M | 8,400 | $0.01 | $42 | 13,573 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Oct 1 | Oct 5 | S | 4,631 | $78.09 | Sale −$361,635 | 8,942 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Oct 1 | Oct 5 | S | 2,970 | $78.82 | Sale −$234,095 | 5,972 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Oct 1 | Oct 5 | S | 799 | $79.67 | Sale −$63,656 | 5,173 | Yes | Form 4 |
| MNPRMonopar Therapeutics | Oct 1 | Oct 5 | M · derivative | 8,400 | $0.01 | $42 | 8,400 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.